A phase 1b/2 study of omaveloxolone in combination with checkpoint inhibitors in patients with unresectable or metastatic melanoma

被引：0
|
作者：
Patel, S. P. [1 ]
Hodi, F. S. [2 ]
Gabrilovich, D. [3 ]
Chin, M. [4 ]
Gibney, G. [5 ]
Goldsberry, A. [4 ]
Gonzalez, R. [6 ]
Hurt, J. [4 ]
Markowitz, J. [7 ]
Whitman, E. [8 ]
Meyer, C. [4 ]
Salama, A. [9 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Wistar Inst Anat & Biol, Immunol, 3601 Spruce St, Philadelphia, PA 19104 USA
[4] Reata Pharmaceut, Prod Dev, Irving, TX USA
[5] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[6] Univ Colorado, Sch Med, Denver, CO USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol, Tampa, FL USA
[8] Atlantic Hlth Syst Canc Care, Morristown, NJ USA
[9] Duke Univ, Sch Med, Durham, NC USA
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5O_PR
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
    Gibney, Geoffrey T.
    Hamid, Omid
    Lutzky, Jose
    Olszanski, Anthony J.
    Mitchell, Tara C.
    Gajewski, Thomas F.
    Chmielowski, Bartosz
    Hanks, Brent A.
    Zhao, Yufan
    Newton, Robert C.
    Maleski, Janet
    Leopold, Lance
    Weber, Jeffrey S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] PHASE 1B STUDY OF LNS8801 IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH SECONDARY RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS
    Rodon, Jordi
    Chaney, Marya
    Cohen, Justine
    Garyantes, Tina
    Lin, Jessica
    Lorusso, Patricia
    Mita, Alain
    Mita, Monica
    Muller, Carolyn
    Natale, Christopher
    Orloff, Marlana
    Papadopoulos, Kyriakos
    Patel, Sapna
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A791 - A791
  • [3] A PHASE 1B/2 STUDY OF CABOZANTINIB IN COMBINATION WITH PEMBROLIZUMAB IN ADVANCED MELANOMA
    Jain, Jayanshu
    Frees, Melanie
    Yasin, Hesham
    Bonner, Jaime
    Freesmeier, Michele
    Garje, Rohan
    Venur, Vyshak Alva
    Milhem, Mohammed
    Zakharia, Yousef
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A260 - A260
  • [4] Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
    Tolaney, Sara M.
    Jhaveri, Komal
    Helsten, Teresa
    Puhalla, Shannon L.
    Conlin, Alison
    Dees, E. Claire
    Beeram, Muralidhar
    Chapman, Sonya C.
    Lithio, Andrew
    Litchfield, Lacey M.
    Goetz, Matthew P.
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [5] Motesanib (AMG 706) in combination with paclitaxel or docetaxel: phase 1b study in patients with locally recurrent, unresectable or metastatic breast cancer
    Kaufman, P.
    de Boer, R.
    White, S.
    Mainwaring, P.
    Koczwara, B.
    Urquhart, L. M.
    Ye, Y.
    Sun, Y.
    Adewoye, H.
    Kotasek, D.
    EJC SUPPLEMENTS, 2009, 7 (02): : 269 - 269
  • [6] A Phase 1-2 Study of Imexon Plus Dacarbazine in Patients With Unresectable Metastatic Melanoma
    Weber, Jeffrey S.
    Samlowski, Wolfram E.
    Gonzalez, Rene
    Ribas, Antoni
    Stephenson, Joe
    O'Day, Steven
    Sato, Takami
    Dorr, Robert
    Grenier, Kathryn
    Hersh, Evan
    CANCER, 2010, 116 (15) : 3683 - 3691
  • [7] Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer
    Rebecca A. Shatsky
    Hemali Batra-Sharma
    Teresa Helsten
    Richard B. Schwab
    Emily I. Pittman
    Minya Pu
    Elizabeth Weihe
    Emanuela M. Ghia
    Laura Z. Rassenti
    Alfredo Molinolo
    Betty Cabrera
    James B. Breitmeyer
    George F. Widhopf II
    Karen Messer
    Catriona Jamieson
    Thomas J. Kipps
    Barbara A. Parker
    Breast Cancer Research, 26
  • [8] Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study
    Ferrucci, Pier F.
    Minchella, Ida
    Mosconi, Massimo
    Gandini, Sara
    Verrecchia, Francesco
    Cocorocchio, Emilia
    Passoni, Claudia
    Pari, Chiara
    Testori, Alessandro
    Coco, Paola
    Munzone, Elisabetta
    MELANOMA RESEARCH, 2015, 25 (03) : 239 - 245
  • [9] Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
    Yao, Yuan
    Yan, Yiyi
    Suman, Vera J.
    Dietz, Allan B.
    Erskine, Courtney L.
    Dimou, Anastasios
    Markovic, Svetomir N.
    Mcwilliams, Robert R.
    Montane, Heather N.
    Block, Matthew S.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [10] A Phase 1b Dose-Escalation Study of Carotuximab in Combination with Nivolumab in Patients with Metastatic NSCLC
    Robert, F.
    Gray, J. E.
    Trigeiro, A.
    Adams, B.
    Theuer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S725 - S726
12345